EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Resveratrol and its metabolites elicit neuroprotection via high‐affinity binding to the laminin receptor at low nanomolar concentrations

Rayudu Gopalakrishna iD, Jennifer Aguilar, Andrew Oh, Emily Lee, Lucas Hou, Tammy Lee, Eric Xu, James Nguyen, William J Mack

FEBS Letters · 2024

DOI: 10.1002/1873-3468.14835 ↗

Kurz gefasst

Fachartikel in der Zeitschrift FEBS Letters, 2024. Verfasst von Rayudu Gopalakrishna und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrative Anatomical Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. Hauptthemen laut MEDLINE: Resveratrol, Receptors, Laminin, Neuroprotective Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Resveratrol prevents various neurodegenerative diseases in animal models despite reaching only low nanomolar concentrations in the brain after oral administration. In this study, based on the quenching of intrinsic tryptophan fluorescence and molecular docking, we found that trans ‐resveratrol, its conjugates (glucuronide and sulfate), and dihydro‐resveratrol (intestinal microbial metabolite) bind with high affinities ( K d , 0.2–2 n m ) to the peptide G palindromic sequence (near glycosaminoglycan‐binding motif) of the 67‐kDa laminin receptor (67LR). Preconditioning with low concentrations (0.01–10 n m ) of these polyphenols, especially resveratrol‐glucuronide, protected neuronal cells from death induced by serum withdrawal via activation of cAMP‐mediated signaling pathways. This protection was prevented by a 67LR‐blocking antibody, suggesting a role for this cell‐surface receptor in neuroprotection by resveratrol metabolites.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ResveratrolReceptors, LamininNeuroprotective AgentsHumansMolecular Docking SimulationAnimalsProtein BindingNeuronsStilbenesNeuroprotectionSignal TransductionBinding SitesGlucuronidesRibosomal Proteins

Stichwörter der Autor:innen

67‐kDa laminin receptorcAMPepigallocatechin‐3‐gallateglycosaminoglycanneuroprotectionresveratrol‐3‐glucuronide

Substanzen

ResveratrolReceptors, LamininNeuroprotective AgentsRPSA protein, humanStilbenesGlucuronidesRibosomal Proteins

Autor:innen und Institutionen

  • Department of Integrative Anatomical Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Department of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

ORCID-Profile: Rayudu Gopalakrishna

Förderung

  • NINDS NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Gopalakrishna, R., Aguilar, J., Oh, A., Lee, E., Hou, L., Lee, T., Xu, E., Nguyen, J., & Mack, W. J. (2024). Resveratrol and its metabolites elicit neuroprotection via high‐affinity binding to the laminin receptor at low nanomolar concentrations. FEBS Letters. https://doi.org/10.1002/1873-3468.14835

Vancouver

Gopalakrishna R, Aguilar J, Oh A, Lee E, Hou L, Lee T, et al. Resveratrol and its metabolites elicit neuroprotection via high‐affinity binding to the laminin receptor at low nanomolar concentrations. FEBS Letters. 2024. doi:10.1002/1873-3468.14835

BibTeX
@article{Gopalakrishna2024,
  author = {Gopalakrishna, Rayudu and Aguilar, Jennifer and Oh, Andrew and Lee, Emily and Hou, Lucas and Lee, Tammy and Xu, Eric and Nguyen, James and Mack, William J},
  title = {Resveratrol and its metabolites elicit neuroprotection via high‐affinity binding to the laminin receptor at low nanomolar concentrations},
  journal = {FEBS Letters},
  year = {2024},
  doi = {10.1002/1873-3468.14835}
}
Kostenlos starten →